253 results on '"Szymonifka, Jackie"'
Search Results
2. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: The BIOCRT study
3. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays
4. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway
5. Impact of Aortomitral Continuity Calcification on Need for Permanent Pacemaker After Transcatheter Aortic Valve Replacement
6. Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients
7. Living in immigrant communities does not impact total knee arthroplasty outcomes: experience from a high-volume center in the United States
8. Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double‐Blind, Placebo‐Controlled, Pilot Trial
9. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy
10. Spatial environmental factors predict cardiovascular and all-cause mortality: Results of the SPACE study
11. Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103
12. Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy
13. Superior results of Total Therapy 3 (2003-33) in gene expression profiling–defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance
14. Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry
15. Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols
16. Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry.
17. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
18. Responsiveness of PROMIS® Global Health Short Form in Outpatients with Systemic Lupus Erythematosus
19. Cardiovascular disease risk prediction for people with type 2 diabetes in a population-based cohort and in electronic health record data
20. Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker
21. Computed Tomography−Guided Assessment of Response to Cardiac Resynchronization Therapy
22. Association of Traditional Chinese Medicine Use With Adherence to Prescribed Western Rheumatic Medications Among Chinese American Patients: A Cross‐Sectional Survey
23. Responsiveness of the Patient‐Reported Outcomes Measurement Information System Global Health Short Form in Outpatients With Systemic Lupus Erythematosus
24. 1409-P: Diabetes Development in Adults with Cardiovascular Disease: Age Matters
25. Left ventricular wall thickness assessed by cardiac computed tomography and cardiac resynchronization therapy outcomes
26. Relationship of soluble ST2 to pulmonary hypertension severity in patients undergoing cardiac resynchronization therapy
27. Racial Disparities in Total Knee Replacement Failure As Related to Poverty
28. Performance of Dynamic Automated CT Annular Measurements Compared with Standard Manual Measurements for Transcatheter Aortic Valve Replacement Sizing
29. Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Patients With Rheumatoid Arthritis in Clinical Remission
30. 3047 Patient-Reported Outcomes Measurement Information System (PROMIS®) Global Health Short Form is Responsive to Patient Reported Changes in Systemic Lupus Erythematosus
31. Left ventricular wall thickness assessed by cardiac computed tomography and cardiac resynchronization therapy outcomes.
32. Does Education Level Mitigate the Effect of Poverty on Total Knee Arthroplasty Outcomes?
33. Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography
34. Development and Validation of a Simple-to-Use Nomogram for Predicting 5-, 10-, and 15-Year Survival in Asymptomatic Adults Undergoing Coronary Artery Calcium Scoring
35. Belimumab for the Treatment of Early Diffuse Systemic Sclerosis
36. The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin
37. CIRCULATING CONCENTRATIONS OF OREXIN A ARE ASSOCIATED WITH LEFT VENTRICULAR REVERSE REMODELING AND CLINICAL OUTCOMES FOLLOWING CARDIAC RESYNCHRONIZATION THERAPY
38. Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study
39. Abstract 13924: Four-Tier Classification of Pulmonary Artery Metric Severity for Diagnosis and Prognosis of Pulmonary Hypertension
40. Prognostic Significance of Treatment-Induced Pathologic Necrosis in Extremity and Truncal Soft Tissue Sarcoma after Neoadjuvant Chemoradiotherapy
41. Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer
42. Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis
43. USEFULNESS OF ATHEROSCLEROTIC PLAQUE DIFFUSENESS AND VOLUME BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR PREDICTING CORONARY LESION-SPECIFIC ISCHEMIA BY FRACTIONAL FLOW RESERVE
44. DUAL-SOURCE COMPUTED TOMOGRAPHY TO IMPROVE PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY (DIRECT): A PROSPECTIVE DOUBLE-BLIND RANDOMIZED STUDY
45. SERIAL COMPUTED TOMOGRAPHY PULMONARY ARTERIAL MEASUREMENTS PREDICT SURVIVAL IN PULMONARY HYPERTENSION PATIENTS
46. SOLUBLE ST2 IS AFFECTED BY PULMONARY HYPERTENSION SEVERITY IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
47. Static and dynamic assessment of myocardial perfusion by computed tomography
48. Abstract 17471: Cardiorenal Syndrome Patients With High NT-proBNP and Cystatin C Levels and Patients With Irreversible Cardiorenal Syndrome Identified by Persistently High Levels of Cystatin C Have Worse Outcomes in Cardiac Resynchronization Therapy: The BIOCRT Study
49. Abstract 16574: Heart Failure Biomarkers (NT-proBNP, Gal-3, sST2) Correlate With Right Ventricular Systolic Pressure and Provide Insight to Poor CRT Response: A BIOCRT Substudy
50. Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.